These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 11253602

  • 1. Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer.
    Garland L, Robinson LA, Wagner H.
    Chest Surg Clin N Am; 2001 Feb; 11(1):69-100, viii. PubMed ID: 11253602
    [Abstract] [Full Text] [Related]

  • 2. Stage IIIB non-small-cell lung cancer.
    Rendina EA, Venuta F, De Giacomo T, Furio Coloni G.
    Chest Surg Clin N Am; 2001 Feb; 11(1):101-19, viii. PubMed ID: 11253593
    [Abstract] [Full Text] [Related]

  • 3. Management algorithms for stage IIIA non-small cell lung cancer with N2 node involvement.
    Detterbeck F, Sukumar MS.
    Thorac Surg Clin; 2008 Nov; 18(4):437-41, vii. PubMed ID: 19086612
    [Abstract] [Full Text] [Related]

  • 4. The management of non-small-cell lung cancer with oligometastases.
    Downey RJ, Ng KK.
    Chest Surg Clin N Am; 2001 Feb; 11(1):121-32, ix. PubMed ID: 11253594
    [Abstract] [Full Text] [Related]

  • 5. Stage IIIA N2 non-small-cell lung cancer: current controversies in combined-modality therapy.
    Thomas PA.
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):431-2. PubMed ID: 19524447
    [No Abstract] [Full Text] [Related]

  • 6. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
    Van Meerbeeck JP, De Pauw R, Tournoy K.
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
    [Abstract] [Full Text] [Related]

  • 7. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
    van Meerbeeck JP, Surmont VF.
    Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
    [Abstract] [Full Text] [Related]

  • 8. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
    Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB, Rice DC, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Roth JA.
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1601-10. PubMed ID: 16308005
    [Abstract] [Full Text] [Related]

  • 9. Stage II (N1) lung cancer.
    Choy O, Jahan T, Roach M, You L, Jablons D.
    Chest Surg Clin N Am; 2001 Feb; 11(1):39-59, viii. PubMed ID: 11253600
    [Abstract] [Full Text] [Related]

  • 10. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.
    Uy KL, Darling G, Xu W, Yi QL, De Perrot M, Pierre AF, Waddell TK, Johnston MR, Bezjak A, Shepherd FA, Keshavjee S.
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):188-93. PubMed ID: 17599507
    [Abstract] [Full Text] [Related]

  • 11. Treatment of stage I lung cancer.
    Walsh GL, Pisters KM, Stevens C.
    Chest Surg Clin N Am; 2001 Feb; 11(1):17-38, vii. PubMed ID: 11253597
    [Abstract] [Full Text] [Related]

  • 12. Stage II (T3) lung cancer.
    Allen MS, Jett JR, Kozelsky TF.
    Chest Surg Clin N Am; 2001 Feb; 11(1):61-7. PubMed ID: 11253601
    [Abstract] [Full Text] [Related]

  • 13. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a closer look at redo mediastinoscopy.
    Granone P, Van Schil P, Cesario A.
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):275-6; author reply 276-7. PubMed ID: 17198837
    [No Abstract] [Full Text] [Related]

  • 14. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
    Keller SM, Vangel MG, Wagner H, Schiller JH, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH, Eastern Cooperative Oncology Group.
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
    [Abstract] [Full Text] [Related]

  • 15. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F, De Pas T, Catalano G, Piperno G, Curigliano G, Solli P, Veronesi G, Petrella F, Spaggiari L.
    J Natl Cancer Inst; 2007 Aug 01; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract] [Full Text] [Related]

  • 16. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study.
    Cerfolio RJ, Bryant AS, Ojha B.
    J Thorac Cardiovasc Surg; 2006 Jun 01; 131(6):1229-35. PubMed ID: 16733150
    [Abstract] [Full Text] [Related]

  • 17. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
    Koukourakis M.
    Rev Pneumol Clin; 2001 Nov 01; 57(5 Pt 2):S33-6. PubMed ID: 11924241
    [No Abstract] [Full Text] [Related]

  • 18. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.
    Thomas M, Hoffknecht P, Droege C, Baisch A, Reinmuth N, Kreuter M, Lange T, Berdel WE.
    Lung Cancer; 2004 Aug 01; 45 Suppl 2():S99-105. PubMed ID: 15552789
    [Abstract] [Full Text] [Related]

  • 19. Combined modality therapy for non-small cell lung carcinoma.
    Machtay M, Glatstein E.
    Cancer J; 2002 Aug 01; 8 Suppl 1():S55-67. PubMed ID: 12075703
    [Abstract] [Full Text] [Related]

  • 20. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, Kato H, Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group.
    J Thorac Cardiovasc Surg; 2003 Feb 01; 125(2):254-60. PubMed ID: 12579093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.